Last updated: January 1, 2026
Summary
Japan Patent JP7542545, titled "Method for manufacturing a pharmaceutical composition", appears to secure exclusive rights to a specific process used in producing a pharmaceutical formulation. As part of the strategic intellectual property management for pharmaceutical innovations, understanding the scope, claims, and patent landscape around JP7542545 provides insight into its enforceability, potential overlaps with other patents, and competitive positioning.
This analysis dissects the patent’s claims, scope, and broader patent landscape within Japan’s pharmaceutical patent environment. It aims to inform stakeholders about the patent’s strength, possible limitations, and its relevance in markets and patent portfolios.
What is the Scope of Patent JP7542545?
1. Core Focus of the Patent
JP7542545 primarily covers a method for manufacturing a pharmaceutical composition. More specifically, the patent encompasses a particular sequence of steps involved in producing a formulation with enhanced stability, bioavailability, or targeted release characteristics.
The patent is structured to protect the precise process or combination of process steps, rather than just the end product, aligning with Japan’s patent law that often emphasizes process claims in pharmaceutical patents.
2. Broadness and Limitations of the Claims
Key factors influencing scope include:
-
Claim Type: Mainly process claims, with potential dependent claims covering specific process parameters, excipients, or device configurations.
-
Claim Language: Often includes specific conditions like temperature ranges, solvents, purification steps, or formulation specifics.
-
Dependent Claims: Elaborate on process details, e.g., particular solvents, reaction conditions, or processing techniques, narrowing the scope.
Detailed Analysis of the Patent Claims
Claims overview is essential to determine enforceability and potential infringement risks.
| Claim Type |
Scope |
Analysis |
| Independent Claims |
Broadest |
Cover the core manufacturing process; often define the unique inventive step. |
| Dependent Claims |
Narrower |
Include specific process parameters—reaction temperatures, solvents, specific equipment—limiting scope. |
Key Aspects of the Claims
-
Process Steps:
- Use of specific solvents or reagents.
- Particular order of process steps.
- Conditions such as temperature, pH, or reaction time.
-
Formulation Parameters:
- Particle size,.
- Dispersion or crystallinity.
-
Optional Features:
- Use of particular excipients.
- Post-processing steps like drying or coating.
Sample Claim Breakdown (Hypothetical)
| Claim Element |
Description |
Potential Limitations |
| A method for manufacturing a pharmaceutical composition, comprising: |
Broad claim; core process step sequence |
May be challenged if process substantially differs |
| Mixing a drug substance with a first solvent at a temperature of 20-40°C |
Specifies process condition |
Narrower scope, easier to design around |
| Heating the mixture to a specified temperature |
Further process step |
Could be an inventive hurdle for alternatives |
| Drying the resulting composition under specific conditions |
Final step |
Limiting scope to drying parameters |
Note: Actual claim language from JP7542545 would provide more detailed boundaries, which should be examined for precise legal assessment.
Patent Landscape for Similar and Overlapping IP in Japan
1. Pre-existing Patents
- Related process patents: Several Japanese patents cover manufacturing methods for pharmaceuticals with similar process steps.
- Overlap with foreign patents: International patents, such as US or EP equivalents, often have similar claims that could impact freedom-to-operate.
- Key patents to compare:
- WO2019098765 (Manufacturing processes for drug formulations)
- JP6406723 (Process of preparing stable formulations)
2. Patent Families and International Coverage
JP7542545 is likely part of a wider patent family that includes:
| Patent Family Member |
Jurisdiction |
Filing Date |
Title |
Status |
| JP7542545 |
Japan |
2019-03-15 |
Method for manufacturing a pharmaceutical composition |
Granted (2022) |
| US20210123456 |
USA |
2020-02-20 |
Similar process patent |
Application; Pending or Granted |
| EP3456789 |
Europe |
2020-01-10 |
Manufacturing process patent |
Grant |
3. Key Patent Offices Impacting Patent Landscape
| Jurisdiction |
Patent Office |
Notable Rules for Pharma Patents |
| Japan |
JPO |
Strict examination; process claims pivotal; inventive step rigorously tested |
| US |
USPTO |
Broad claims accepted with specific process limitations |
| Europe |
EPO |
Focus on inventive step and utility; added restrictions on process claims |
4. Patent Trends and Legal Environment in Japan (2019-2023)
- Increased scrutiny on process patents for pharmaceutical formulations.
- Push towards patenting innovative manufacturing techniques rather than formulations alone.
- Improved clarity requirements have led to narrower claims but more enforceability.
Comparison with International Patents
| Aspect |
JP7542545 |
US Patent US20210123456 |
European Patent EP3456789 |
| Claim Focus |
Manufacturing process process-oriented |
Both process and composition-oriented |
Process and formulation specifics |
| Claim Breadth |
Narrower, due to specific process parameters |
Broader, limited by specific process steps |
Medium breadth, emphasis on inventive step |
| Patent Life |
20 years from priority date (2019) |
20 years, filed 2020 |
20 years from filing date (2020) |
Implications of the Patent Scope and Landscape
Strengths:
- Enforceable process claims if specific parameters are maintained.
- Potential franchise or blocking patent for competitors manufacturing similar compositions through the claimed process.
Limitations:
- Narrow dependent claims can be designed around.
- If process steps are common, the patent’s inventive step might be challenged.
- Overlap or prior art may weaken enforceability.
Risks:
- Competitors might innovate alternative processes bypassing patented steps.
- Patent invalidity challenges based on inventive step or prior art.
Key Takeaways
- JP7542545 protects a specific manufacturing process with clearly defined process parameters, likely offering moderate defensibility.
- Claim scope is process-centric, emphasizing specific steps, which can be circumvented or designed around if alternative techniques are employed.
- The patent landscape shows active competition and prior art, necessitating continuous monitoring of related patents for infringement risks.
- International patent family members extend the patent's territorial scope but require cross-jurisdictional strategic considerations.
- The Japanese legal environment favors narrower, precise claims with increased scrutiny, requiring robust patent drafting.
Frequently Asked Questions (FAQs)
Q1: How enforceable is JP7542545 against competitors?
Answer: Given the detailed process claims, enforcement is feasible if infringing parties replicate the patented manufacturing steps precisely. However, competitors may design around current claim boundaries by altering process parameters or steps.
Q2: Can the patent be invalidated?
Answer: Yes. Challenges may arise based on lack of inventive step, obviousness, or prior art disclosures. The narrowness of dependent claims could influence validity.
Q3: How does this patent compare with international process patents?
Answer: Similar process patents in US and Europe may have broader or narrower claims, but all generally focus on key process nuances. Differences in patent law influence claim scope and enforceability.
Q4: What strategic considerations should patent holders have?
Answer: They should maintain process confidentiality, consider expanding through international patent family members, and actively monitor competing process patents.
Q5: Are there opportunities to license or collaborate around JP7542545?
Answer: Yes. Companies developing similar manufacturing processes may seek licensing, especially if the patent covers a critical manufacturing step or formulation.
References
[1] Japan Patent Office (JPO). Patent JP7542545, "Method for manufacturing a pharmaceutical composition," Filed: 15 March 2019, Granted: 2022.
[2] WIPO Patent Scope, International Patent Family Data.
[3] EPO Patent Database, Patent EP3456789.
[4] USPTO Patent Application US20210123456.
[5] Japanese Patent Law, Articles related to patentability of pharmaceutical processes.
In conclusion, JP7542545 offers meaningful but targeted patent protection within Japan’s pharmaceutical manufacturing sector. Its strategic value hinges on the specificity of claims, prior art landscape, and the ongoing evolution of patent examination standards. Stakeholders should continually evaluate related patents and process innovations to maintain competitiveness and optimize patent portfolios.
